Controversies in the temperature management of critically ill patients

被引:9
|
作者
Nakajima, Yasufumi [1 ]
机构
[1] Kansai Med Univ, Dept Anesthesiol & Intens Care, Shinmachi 2-3-1, Hirakata, Osaka 5731191, Japan
基金
日本学术振兴会;
关键词
Therapeutic hypothermia; Fever; Temperature management; Intensive care; HOSPITAL CARDIAC-ARREST; EUROPEAN RESUSCITATION COUNCIL; AMERICAN-HEART-ASSOCIATION; EARLY PEAK TEMPERATURE; CARDIOPULMONARY-RESUSCITATION; BODY-TEMPERATURE; MILD HYPOTHERMIA; THERMOREGULATORY RESPONSES; PREHOSPITAL INDUCTION; CUTANEOUS VASODILATOR;
D O I
10.1007/s00540-016-2200-7
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Although body temperature is a classic primary vital sign, its value has received little attention compared with the others (blood pressure, heart rate, and respiratory rate). This may result from the fact that unlike the other primary vital signs, aging and diseases rarely affect the thermoregulatory system. Despite this, when humans are exposed to various anesthetics and analgesics and acute etiologies of non-infectious and infectious diseases in perioperative and intensive care settings, abnormalities may occur that shift body temperature up and down. A recent upsurge in clinical evidence in the perioperative and critical care field resulted in many clinical trials in temperature management. The results of these clinical trials suggest that aggressive body temperature modifications in comatose survivors after resuscitation from shockable rhythm, and permissive fever in critically ill patients, are carried out in critical care settings to improve patient outcomes; however, its efficacy remains to be elucidated. A recent, large multicenter randomized controlled trial demonstrated contradictory results, which may disrupt the trends in clinical practice. Thus, updated information concerning thermoregulatory interventions is essential for anesthesiologists and intensivists. Here, recent controversies in therapeutic hypothermia and fever management are summarized, and their relevance to the physiology of human thermoregulation is discussed.
引用
收藏
页码:873 / 883
页数:11
相关论文
共 50 条
  • [31] Management of invasive candidiasis in critically ill patients
    Blot, S
    Vandewoude, K
    DRUGS, 2004, 64 (19) : 2159 - 2175
  • [32] Hyperglycemia and Insulin Management in Critically Ill Patients
    Wong, Sandy
    Tran, Michael D.
    Tsu, Laura
    US PHARMACIST, 2021, 46 (11) : HS7 - HS12
  • [33] Management of psychiatric problems in critically ill patients
    Eisendrath, SJ
    Shim, JJ
    AMERICAN JOURNAL OF MEDICINE, 2006, 119 (01): : 22 - 29
  • [34] Medical management of bleeding in critically ill patients
    Ridley, Saxon
    Taylor, B.
    Gunning, K.
    BJA EDUCATION, 2007, 7 (04) : 116 - 121
  • [35] Management of Atrial Fibrillation in Critically Ill Patients
    Arrigo, Mattia
    Bettex, Dominique
    Rudiger, Alain
    CRITICAL CARE RESEARCH AND PRACTICE, 2014, 2014
  • [36] Airway management in critically ill patients - Response
    Walz, J. Matthias
    Zayaruzny, Maksim
    Heard, Stephen O.
    CHEST, 2007, 132 (05) : 1714 - 1715
  • [37] Fluid management in perioperative and critically ill patients
    Kang, Dongho
    Yoo, Kyung Yeon
    ACUTE AND CRITICAL CARE, 2019, 34 (04) : 235 - 245
  • [38] Management of tracheobronchial ruptures in critically ill patients
    Conti, M.
    Porte, H.
    Wurtz, A.
    MINERVA ANESTESIOLOGICA, 2007, 73 (7-8) : 443 - 443
  • [39] Individualized glycemic management for critically ill patients
    Tomoya Okazaki
    Akihiko Inoue
    Yasuhiro Kuroda
    Intensive Care Medicine, 2022, 48 : 126 - 127
  • [40] Delirium and delirium management in critically ill patients
    Kersten, A.
    Reith, S.
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2016, 111 (01) : 14 - 21